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Background: Retroviral integrases (INs) catalyze the integration of viral DNA in the chromosomal DNA of the
infected cell. This reaction requires the multimerization of IN to coordinate a nucleophilic attack of the 3’ ends of
viral DNA at two staggered phosphodiester bonds on the recipient DNA. Several models indicate that a tetramer of
IN would be required for two-end concerted integration. Complementation assays have shown that the N-terminal
domain (NTD) of integrase is essential for concerted integration, contributing to the formation of a multimer
through protein-protein interaction. The isolated NTD of Mo-MLV integrase behave as a dimer in solution however
the structure of the dimer in solution is not known.
Results: In this work, crosslinking and mass spectrometry were used to identify regions involved in the dimerization
of the isolated Mo-MLV NTD. The distances between the crosslinked lysines within the monomer are in agreement
with the structure of the NTD monomer found in 3NNQ. The intermolecular crosslinked peptides corresponding to
Lys 20-Lys 31, Lys 24-Lys 24 and Lys 68-Lys 88 were identified. The 3D coordinates of 3NNQ were used to derive a
theoretical structure of the NTD dimer with the suite 3D-Dock, based on shape and electrostatics complementarity,
and filtered with the distance restraints determined in the crosslinking experiments.
Conclusions: The crosslinking results are consistent with the monomeric structure of NTD in 3NNQ, but for the
dimer, in our model both polypeptides are oriented in parallel with each other and the contacting areas between
the monomers would involve the interactions between helices 1 and helices 3 and 4.Background
Protein-protein interactions play a fundamental role on
the assembly of multimeric complexes of IN to carry out
two-end concerted DNA integration [1-3]. Retroviral
integrase structures are organized in three domains, a
central domain that contain the catalytic site (CCD), a
N-terminal domain (NTD) that binds zinc and a C-
terminal domain (CTD) having a SH3 fold [4].
Biochemical and genetic studies have shown that the
NTD of integrase (IN) is involved in protein-protein* Correspondence: oleon@med.uchile.cl
1Programa de Virologia ICBM, Facultad de Medicina, Universidad de Chile,
Independencia 1027, Santiago, Chile
Full list of author information is available at the end of the article
© 2013 Henriquez et al.; licensee BioMed Cen
Creative Commons Attribution License (http:/
distribution, and reproduction in any mediuminteractions favoring protein multimerization and
stabilization of the DNA-IN complex [5-8]. Prototype
foamy virus (PFV) structure shows binding of this do-
main to LTR [9]. A polypeptide containing the first
105 amino acids of Mo-MLV IN, expressed in E. coli,
is functionally active since it complements in trans an
IN mutant lacking the NTD. Gel filtration chroma-
tography indicates that this NTD behaves as a dimer
in solution [8]. Similar observations have been made
in HIV-1 IN [6]. The 3D structure of HIV-1 IN NTD,
solved by NMR showed the dimer interface is highly
hydrophobic and it includes the α-helices 3 and 4,
and the N-terminal of helix 1 [10].
The NTD is essential for 3’ processing and strand
transfer, however determining its role in the integrationtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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difficult due to the absence of the full-length structure
of IN and the complexity of the protein-protein and
protein-DNA interactions involved in the synaptic com-
plex. Several models based on the partial 3D structure of
IN fragments have been proposed for HIV-1 IN and
ASV [11-13]. The X-ray structure of a tetrameric
integrase complex of the PFV IN and processed U5
DNA was solved [14-16]. In this complex, the NTDs of
the external subunits have been located at distal posi-
tions of the complex [17], however their structure was
unresolved in the crystal structure. The quaternary
structure of HIV integrase in solution has been exam-
ined by small and wide X-ray angle scattering and chem-
ical crosslinking [18]. It has been concluded that
integrase can assemble as a tetramer by the interaction
of two different dimers: one of them is stabilized by
interactions between the CCDs of two subunits while
the other dimer is stabilized by interactions of one NTD
with the CCD, CTD, and NTD of the other subunit. The
interaction between the NTDs in the latter dimer was
detected by chemical crosslinking [18].
A sequence alignment of the NTD of Mo-MLV, PFV
and HIV-1 integrases is presented in Figure 1. The NTD
of Mo-MLV IN is 45 amino acids larger than the NTD
of HIV-1 IN [8]. PFV IN also contains an extra region of
50 amino acids before the zinc binding domain. Since no
quaternary structural information for Mo-MLV IN is
available, in this work we explored the use of cross-
linking in order to identify lysine residues that are within
the range of the cross-linking spacer within the mono-
mer or the dimer on the NTD. Cross-linked peptides
were identified and sequenced by MALDI-TOF MS/MS
spectroscopy. Based on these results and the 3D coordi-
nates available in 3NNQ, a model of the NTD dimer
was built. This model suggests a parallel arrangement of
the NTDs.
Results and discussion
The NTD of Mo-MLV integrase behaves as a dimer in
solution according to gel filtration on Superose 12 and
favors multimerization of IN [6,8]. In complementation
studies it has been shown that addition of an isolated
NTD domain to an IN construct lacking this domainFigure 1 Sequence alignment of PFV, HIV-1 and Mo-MLV NTD-IN. The
as orange cylinders, and β-strands by blue arrows. Yellow boxes: at least tw
codes: PFV IN, CAA68999; HIV-1 IN, AAC83550 and Mo-MLV IN, P03355.restores the activities of IN. However, there is no infor-
mation on the structure of the dimer of Mo-MLV in so-
lution and how it interacts with the other IN domains.
In this work we carried out chemical crosslinking to
identify lysine residues that were located on the interface
of the dimer in order to determine the regions involved
in dimerization. This procedure involved the analysis of
the crosslinked peptides on the isolated dimer and
uncrosslinked monomers by mass spectrometry [19-21].
Chemical cross-linking of IN 1–105 with BS3
Wild type IN 1–105 and K104C IN 1–105 were
expressed in E. coli and purified by chromatography on
Ni-NTA agarose. The proteins were 95% pure as judged
by SDS-PAGE (result not shown). Wild type IN 1–105
was crosslinked with bis[sulfosuccinimidyl] suberate
(BS3) in 50 mM Hepes pH 7.8 at 25°C. Figure 2A shows
the results of the reaction kinetics using 56 μM of IN 1–
105 and 100 μM BS3. A protein band migrating near
29 kDa corresponds to the expected dimer. In order to
determine the effect of BS3 on IN 1–105 crosslinking,
BS3 (between 0 and 300 μM) was used. The reactions
were carried out at 25°C for 35 min and the results
are shown in Figure 2B. Above 200 μM of BS3, other
high molecular weight products besides the dimer are
observed. 100 μM BS3 was used for crosslinking in
the following experiments. Under these conditions
approximately 50% of the protein was crosslinked.
In order to determine the size of the crosslinked pro-
tein complex, the crosslinking mixture was analyzed by
gel filtration on Superdex S-200 under nondenaturing
conditions. The elution profiles of crosslinked and un-
modified IN 1–105 were almost identical (Figure 3), and
the majority of the crosslinked IN 1–105 (~95%) elutes
at the same position of the unmodified dimer. This
result indicates that, under the conditions of the reac-
tion, intermolecular crosslinking occurs within each
dimer and rules out crosslinking between the dimers.
Identification of intramolecular and intermolecular
crosslinking peptide with BS3
Chemical crosslinking combined with mass spectrometry
(MS) provides a useful method for inferring sites of
protein-protein interactions and for mapping the topologysecondary structure of Mo-MLV is shown below. α-helices are marked
o identical residues, Green boxes: three identical residues. Accession
Figure 2 Chemical cross-linking of IN1-105. The reaction was
carried out in 50 mM Hepes pH 7.8. IN 1 –105 and BS3 was incubated
at 25°C in 40 μL at the times and concentrations indicated. The
reaction was stopped with 50 mM lysine pH 8.0. (A) Crosslinking
kinetics. 56 μM of IN 1–105 were incubated with 100 μM of BS3,
aliquots were removed at the times indicated. Left, SDS-PAGE (15%
acrylamide) silver stained (4 μg of protein were loaded in each lane).
Right, formation of crosslinked IN 1–105 dimer (percent); quantification
of dimeric and monomeric band were carried out with the imageJ
program. (B) Effect of BS3 in crosslinking. 56 μM IN 1–105 and BS3
(0 to 300 μM) were incubated for 35 min at 25°C, aliquots containing
4 μg were loaded on a 12% acrylamide gel. Left, SDS-PAGE (12%)
Coomasie brilliant blue stained gel. Right, formation of crosslinked IN
1–105 dimer.
Figure 3 Characterization of crosslinked product for molecular exclus
Superdex S-200 column equilibrated in 10 mM tris pH 7.5, 0.5 M NaCl, 1 m
fraction were collected. Protein elution was monitored by the absorbance
shown in black, and unmodified control protein is shown in red. The elutio
markers used were: β-amylase (200 kDa), serum albumin (66 kDa), carbonic
void volume (dextran blue).
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crosslinking reagent BS3 that reacts with primary amine
groups of lysines and the NTD integrase of Mo-MLV. In
these experiments IN 1–105 was crosslinked with BS3 and
the dimeric and monomeric band was separated by SDS-
PAGE, subjected to digestion with trypsin or chymotryp-
sin and analyzed by LC-MS/MS as indicated in Materials
and Methods, being compared with the MS/MS profile of
the unmodified IN 1–105, sequencing only differential
peaks (Tables 1 and 2). In these cases only two informative
sequences were used and classified as (1) intramolecular
crosslinked peptides (or looplinks) and (2) intermolecular
crosslinked peptides. Information about intramolecular
crosslinking was obtained from reaction products in
which both functional groups of the crosslinker reacted
with lysine residues that reside in the same polypeptide
chain (see Figures 4 and 5, Table 1). These peptides were
sequenced by MS/MS and corresponded to the intramo-
lecular crosslinking of: (1) residues K88 and K95 in
(TLK88NITETCK95ACAQVNASKS), (2) residues K31 and
K33 in LGAYDK31TK33K, (3) residues K95 and K104 in
NITETCK95ACAQVNASK104S, (4) and residues K88 and
K104 in TLK88NITETCKACAQVNASK104S. The inform-
ative contact position of lysines identified with the
looplinks (see Table 1), was used to analyze the 3D crystal
structure of the NTD of Mo-MLV integrase (3NNQ) in
PDB data bank. We used this structure as a template and
examined the distances between the crosslinked lysines. Aion. 2 mg of IN 1–105 were crosslinked in 200 μL and loaded on a
M DTT and 5% glycerol at a flow rate of 0.5 mL/min. 0.5 mL of each
at 220 nm. The chromatographic profile of the crosslinked protein is
n position of molecular weight markers is indicated by arrows. The
anhydrase (29 kDa) and cytocrome C (12.4 kDa). The (V0) indicated the
Table 1 Looplinked peptides sequences of BS3 crosslinked peptides of Mo-MLV IN NTD and the Cβ distances between
modified lysine residues in the generated model
Crosslinking Peptide 1 Lysine involved Distance (Å)
Looplinks TLK88NITETCK95ACAQVNASKS 88 – 95 15.45
LGAYDK31TK33K 31 – 33 7.32
NITETCK95ACAQVNASK104S 95 – 104 16.15
TLK88NITETCK - ACAQVNASK104S 88 – 104 20.74
The distances were defined using SwissPdbViewer program.
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been used as a restraint for the distance between the Cβ
of two crosslinked lysines using BS3 [22]. The distances
between the crosslinked lysines were within the 21.3 Å
limit, although the crosslinked K88-K104 was near this
limit. Thus, our results are in agreement with the mono-
meric structure of the NTD domain in 3NNQ (Table 1).
The next step was to determine the contact zones of
the dimeric protein-protein interface, using the informa-
tion of the reaction products in which the crosslinked
functional groups belonged to different polypeptides (see
Table 2). Figure 6 shows the profile of one of these dif-
ferential peptides obtained after digestion of the dimeric
band with chymotrypsin. The peptide was sequenced
yielding the sequence TVTDIKDLTK24LGAIY – TK24L,
which contain the crosslinked residues K24 and K24
suggesting the proximity between both N-terminal ends
of the polypeptides. When a similar analysis of the
crosslinked protein was carried out using trypsin, a large
peptide (m/z nearly 5,000) was observed (Figure 7A) that
would correspond to crosslinking between K31 and
either K20 or K24 indicated for the mass of the fragment
(bioworks software analysis) of 4999.5366 m/z. This pep-
tide could not be sequenced by MS/MS due to its large
size. However when the crosslinked IN 1–105 dimer was
digested with chymotrypsin, a peptide corresponding
to crosslinking of residues K20 and K31 on each of
the polypeptide chains was identified and sequenced
(Figure 7B). These results indicate that crosslinking
occurs between K20 and K31 of different polypep-
tides. A third crosslinked peptide was identified after
tryptic digestion of the crosslinked dimer in the MS/MS
sequences as MK68ALLER-TLK88NITETCK indicatingTable 2 Intermolecular peptides sequences of BS3 crosslinked






()* Peptides obtained by chymotrypsin digest.
The distances were defined using SwissPdbViewer program.that K68 and K88 are crosslinked (Figure 8). The intermo-
lecular crosslinking pattern identified shows a particular
distribution along the NTD (see Table 2). These results
allow us to produce a 3D model and characterize the
dimeric interface.
Model of the NTD dimer of Mo-MLV integrase
3D-dock suite was used to generate 10,000 possible
complexes through the rotation and translation of a
mobile monomer (3NNQ), around the fixed coordinates
of another 3NNQ monomer. This set of possible dimers
was filtered using the experimental crosslinking informa-
tion, to select the complex that agrees with the distance
restraint data. A distance of 21.3 Å between crosslinked
lysines was used to select complex candidates. The se-
lected dimers were submitted to an energy minimization
protocol in order to optimize steric and electrostatic
interactions of the residues involved in the protein -
protein interface. All the dimeric structures that satisfied
the distance restraints showed a parallel disposition, with
the residues involved in the crosslinking distributed in
the same longitudinal face of the protein and both poly-
peptide chains arranged in the same direction. The
complex with the more stable interface, according to
Multidock routine of 3D-dock suite, was chosen as the
more probable NTD - NTD dimer. A ribbon representa-
tion of the selected model is presented in Figure 9,
showing the lysine residues that were crosslinked. This
model shows a symmetric and parallel orientation of the
monomers and two points of contact. (1) In the first
α-helix of the N-terminal domain (between K24-K24)
and (2) the fourth α-helix of chain A (blue) with the
fourth α-helix of chain B (brown) of the dimer. Thispeptides of Mo-MLV IN NTD and the Cβ distances
odel
Peptide 2 Lysine involved Distance (Å)
TK24L 24 – 24 * 15.14
FHYTVTDIK20DLTK24LGAIYDK 31 – 20/24 20.02
VTDIK20DLTKL 31 – 20 * 20.02
TLK88NITETCK 68 – 88 13.57
Figure 4 LC-MS/MS peptide map profile of N-terminal domain of Mo-MLV integrase monomer crosslinked gel band digested with
trypsin. (A), in the sample the peak corresponds to the peptide 86–105 with two cross-linked lysines (K88 and K95). (B), the peak corresponds
at the peptide 25–34 with intramolecular cross-linked between K31 and K33, (C) in the monomeric sample the peak corresponds at the peptide
89–105 with intramolecular cross-linked between K95 and K104.
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electrostatic and Van der Waals interactions, where
residues: L 25, D 84, R 85 and D 92 of monomer A
and K 24, L 25, D 84 and D 92 of monomer B, play
the main role in complex stabilization. The complex
is characterized for a ΔASA of 484 Å2, involving 16
residues of the first monomer and 17 residues of the
second monomer. The gain in ΔG of solvation from
the protein-protein interaction was estimated by
PDBePISA server in 2.5 Kcal/Mol (http://www.ebi.ac.
uk/msd-srv/prot_int/cgi-bin/piserver).
The solution structure of the isolated HIV-1 NTD
dimer also exhibits a parallel arrangement [10], however,
structural information on isolated NTDs of other
integrases is not available.It is generally thought that a tetramer is involved in
the integration process. It has been proposed that this
tetramer is assembled by two dimers that differ in their
conformation. Differences in conformation reflect dif-
ferent combinations of interactions between the three
domains of the enzyme. Crosslinking experiments in
solution have revealed NTD-NTD interactions in the
tetramer [18] that were not observed in the crystal struc-
ture of fragments of HIV-1 IN or PFV IN structure. It has
been speculated that this kind of interaction may be
related to a “domain swapping” phenomenon in which an
interaction between the NTD and CCD domains is
substituted by an interaction between the NTDs [18]. It is
possible that this interaction may be evident in the iso-
lated NTDs due to the absence of the CCD domain.
Figure 5 LC-MS/MS peptide map profile of N-terminal domain of Mo-MLV integrase monomer crosslinked gel band. Samples were
digested overnight at 37°C with 0.8 μg of trypsin. The image shows the ionization and sequence of the LC peak (indicated in the inset)
corresponding at the intramolecular peptide 96–105 and 86–95 with K88 and K104 modified.
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In order to test our model, we performed crosslinking
studies introducing cysteine residues at position 104 in
IN1-105 (K104C). This amino acid residue was chosen
because the Cα of both K104 in the 3NNQ dimer is
separated by 28 Å. In contrast, the distance between
these residues in our model is only 10 Å. Therefore
crosslinking with BMOE (8 Å) would be distinguishedFigure 6 LC-MS/MS profile of N-terminal domain of Mo-MLV integras
overnight at 37°C with chymotrypsin in a ratio of 1:20 wt/wt (enzyme: prot
(indicated with asterisk in the inset) corresponding at the intermolecular pebetween both models. The mutant K104C IN1-105 was
obtained by site directed mutagenesis and purified as
described in Materials and Methods. This protein was
able to complement a concerted integration assay that
used a deletion mutant IN lacking the NTD domain
(Figure 10). In addition, IN 1–105 contains two cysteine
residues (C94 and 96) coordinated with zinc, that are
not reactive to N-ethylmaleimide [8]. K104C IN 1–105e cross-linked with BS3. Samples in solution were digested
ein). The image shows the ionization and sequence of the LC peak
ptide 15–29 and 23–25 with K24 and K24 crosslinked.
Figure 7 Intramolecular crosslinking peptide. (A) MALDI-TOF profile of the tryptic digest of dimeric band of IN 1–105 crosslinked with BS3.
Samples were digested overnight at 37°C with trypsin in a ratio of 1:20 wt/wt (enzyme: protein). The image showed the peak 4999.5366 (m/z)
corresponding at the intermolecular peptide 25–33 and 1–31 with K31 and K20 or K24 modified. (B) LC-MS/MS profile of the chymotryptic IN
1–105 were cross-linked with BS3. Samples were digested overnight at 37°C with chymotrypsin in a ratio of 1:20 wt/wt (enzyme:protein).
The image shows the ionization and sequence of the LC peak (indicated in the inset) corresponding at the intermolecular peptide 15–25 and
30–35 with K31 and K20 crosslinked.
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and 14.7 Å in length, respectively. Figure 11 shows that
both reagents produced crosslinked dimer of K104C IN
1–105 (lanes 2 and 3) indicating that the SH groups of
cysteines are within 8 Å. The estimated crosslinking
extent was 65% for BMOE and 70% for BM(PEG)2. The
distance between the cysteines in the 3D coordinates of
3NNQ dimer would be more than 28 Å. Furthermore in
3NNQ both carboxyl ends are separated by interactions
with helix 3 of the other monomer reducing the flexibi-
lity of the polypeptide chain at the position of K104.
In order to confirm that crosslinking was not pro-
duced by the reaction between dimers due to the highreactivity of BMOE with SH groups, the crosslinked re-
action mixture was further analyzed by gel filtration on
superdex S-200. After crosslinking with BMOE most of
the protein eluted as a dimer (not shown).
Conclusions
All retroviral integrases contain a HHCC zinc finger
motif at the N-terminal domain that is involved in
protein-protein interactions, which is essential for retro-
viral integration. The structure of NTD of HIV-1 IN has
been solved by X-ray crystallography and NMR. How-
ever for Mo-MLV with a larger NTD domain, the only
information available is the deposited x-ray structure
Figure 8 Intermolecular crosslinking. LC-MS/MS peptide map profile obtained of the dimer crosslinked gel band of N-terminal domain of
Mo-MLV integrase. The dimer was digested with 0.8 μg of trypsin at 37°C overnight. The image shows the ionization and sequence of the LC
peak (indicated in the inset) corresponding at the intermolecular peptide 67–73 and 86–95 with K68 and K88 crosslinked with BS3.
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metric unit of 3NNQ fails to explain our crosslinking re-
sults. Studies of the isolated Mo-MLV NTD indicates
that the domain behaves as a dimer in solution and as
such is active in complementation of the IN activities.
Therefore our aim was to determine the contacting re-
gions of the NTD domain using chemical crosslinking
and mass spectrometry to identify the dimer present in
solution. Identification of intramolecular crosslinks of
lysines using BS3 as a spacer agree with the conform-
ation of the monomer in 3NNQ. However, the intermo-
lecular crosslinking results did not match the interacting
regions found in 3NNQ dimer.
The current approach to determine protein-protein
interaction in the NTD domain of Mo-MLV integrase
includes the use of the 3D coordinates of the 3NNQ
monomer and experimental distance restraints obtained
using lysines crosslinking and MS/MS sequencing meth-
odologies. We propose a homodimeric model where
both polypeptides are aligned in parallel with the β
strands away from the interface, formed mainly by heli-
ces 1 and 4.
Our model was tested by cysteine crosslinking with
BMOE and as expected a high crosslinking yield was
achieved. We expect that this theoretical model could
be useful to test other properties of the NTD such as
its interactions with the other domains of IN and to
understand the mechanisms used by this HHCC
domains to regulate protein interactions in different
contexts.Methods
Integrase purification
E. coli BL21 (DE3) harboring the plasmid pET/IN 1–105
was used to express IN 1–105 [8]. Protein production
was induced with lactose according to the protocol of
Studier, F. [23]. Cells were grown at 20°C up to 5 O.D.
at 600 nm in 400 mL. Cells were collected by centrifuga-
tion at 6,000 rpm for 30 min in a Sorvall RC-5, GSA
rotor. The pellet was resuspended in 40 mL of lysis buf-
fer (10 mM CHAPS, 10 mM imidazole, 300 mM NaCl,
50 mM NaH2PO4 pH 8,0 and protease inhibitor tablet
(Roche) was sonicated for 6 pulses of 30 s at maximum
intensity (Branson) and the cell debris was removed by
centrifugation at 9,000 rpm for 40 min. 1 mL of Ni-NTA
-agarose was added to the supernatant and mixed over-
night by rotation in a twister VS-96 TW at 4°C. The
resin was washed with 40 mL of buffer 1 (50 mM
NaH2PO4 pH 8.0, 10 mM CHAPS, 1 M NaCl,
10 mM 2-mercaptoethanol, 20% glycerol for 10 min
and the resin was set on a column (BioRad). The col-
umn was washed sequentially with 4 mL of: 25, 50,
100 and 250 mM imidazole dissolved in buffer 1.
Fractions of 1 mL were collected. Protein was quanti-
fied by Bradford (BioRad) and analyzed by SDS-PAGE
on 15% acrylamide gels.
Construction of K104C IN 1–105 mutant
This construct was made by PCR using the plasmid pET
IN1-105 as a template [8] and the mutagenic primer
K104C 5’-AAA AGG ATC CTA AGA GCA GCT GGC
Figure 9 Modeling of dimer conformation of N-terminal domain of Mo-MLV integrase. Visualization of intermolecular crosslinking products
with Swiss-PdbViewer of the dimeric interfase of NTD of Mo-MLV integrase (3NNQ pdb template, experimental crosslinking strain and 3D-Dock suite
used for model). The amino acid involved in the crosslinking and its distances are indicated K31-K20 (green 20.02 Å), K24-K24 (red 15.14 Å) and
K88-K68 (yellow 13.57 Å), all of them are in agreement with the spacer arm of BS3. K104 (light blue) and zinc atoms (yellow) are also indicated.
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and the T7 promoter 5’- CTATAGTGAGTCGTATTA -3’.
The 480 bp PCR product was digested with NdeI and
BamHI (NEB) and purified by electrophoresis in 1.2%
agarose gels and ligated to pET 11b digested with NdeI
and BamHI. The mutation was confirmed by DNA
sequencing.
Chemical crosslinking of IN 1–105
The experimental approach to identify crosslinked ly-
sines is based on the use of homo- bifunctional cross-
linking agents that are directed primarily towards amino
groups. ε-NH2 groups of lysine or the α-NH2 of the
N-terminal amino acid of the protein would poten-
tially react with the N-hydroxysuccinimide ester. This
in turn produces intramolecular crosslinking when ly-
sines of the same polypeptide are located at the appropri-
ate distance. Intermolecular crosslinking can also be
produced when the reactive lysines are located in different
polypeptides. In our approach the reacted protein was
digested with sequencing grade proteases andanalyzed by MALDI TOF/TOF and LC-MS/MS to
identify the position of crosslinking. For the first
round analysis, the data was searched using Bioworks
with +138 (for intra peptide link) and +156 as lysine vari-
able modifications. In these studies the homobifuntional
crosslinker bis(sulfosuccimidyl) suberate (BS3, Pierce) was
used. This crosslinker spans 11.4 Å. 0.4 nmoles of the IN
1–105 (10 μM) was incubated at 25°C in 50 mM Hepes
pH 7.8 and 100 mM NaCl with 100 μM of BS3 for 35 min.
The crosslinking reaction mixture was quenched with a
loading buffer of protein and 50 mM lysine pH 8.0 and
subjected to SDS-PAGE and stained with Coomasie
Brilliant Blue. Under these conditions 50% of IN 1–
105 was crosslinked. The protein band corresponding
to the crosslinked dimer was excised and digested
with trypsin for mass spectrometry analysis.
Characterization of crosslinked products of IN 1–105 by
gel filtration
1.3 mg of protein in 2 mL was crosslinked as described
above. The reaction products were concentrated 10-fold
Figure 11 Cysteine cross-linking. The reaction was carried out in
50 mM Tris–HCl pH 7.0. 50 μM of IN 1–105 K104C in buffer without
crosslinker (control lane) or in the presence of 1 mM of the
bi-functional maleimide crosslinker BMOE or BM(PEG)2. The reaction
was done on ice for 60 min and quenched with 10 mM DTT.
Figure 10 Enzyme activity assays of wild type and IN mutants.
Integration assays were carried out with 7 pmol of wild type IN or 56
pmoles of IN 1–105 (or mutant K105C) and 7 pmoles of IN 106–404 for
complementation assay. The products were electrophoresed on
agarose gels. The upper product corresponds to non-concerted
integration and the lower product to concerted integration. The
substrate migrated off the gel.
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1.3 mg of protein (200 μL) was loaded on a Superdex S-
200 column (30 × 1.7 cm Pharmacia), equilibrated with
10 mM Tris HCl pH 7.5, 0.5 M NaCl, 1 mM DTT and
5% glycerol which were connected to a diode array de-
tector (Jasco). Fractions of 0.5 mL were collected and
the protein visualized by SDS-PAGE 12% and Coomasie
Brilliant Blue staining.
Proteolytic digestion in gel
The stained gel piece was incubated with 1 mL of
50 mM of NH4HCO3 in 50% v/v acetonitrile for 1 h or
until the stain disappeared. Then, the protein was re-
duced with 60 μL of 20 mM DTT in 50 mM NH4HCO3
for 15 min at 60°C. The solution was removed and the
gel was treated with 40 mM iodoacetamide in 50 mM
NH4HCO3 for 30 min at 37°C, in the dark. The gel piece
was washed with 50 mM NH4HCO3 in 50% v/v aceto-
nitrile and with 100% acetonitrile twice and dried
10 min at room temperature, then 0.8 μg of trypsin in
40 μL of 25 mM NH4HCO3, pH 7.8 were added and
incubated at 37°C for 16 h. Peptides were recovered by
concentration in speed vac and analyzed by LC-MS/MS
(U3000 from Dionex and LTQ from Thermofisher) or
MALDI-TOF/TOF (Applied biosystem).
Proteolytic digestion in solution
The crosslinking reaction mixture (0.4 nmoles of pro-
tein) in 50 mM NH4HCO3 was treated with 20 mM
iodoacetamide for 30 min at 37°C. The reaction was
stopped by the addition of 20 mM DTT for 15 min.
Then, trypsin in a ratio 1:20 (wt/wt) was added, and the
digestion was carried out at 37°C for 16 h. The digested
peptides were then analyzed by nano LC-MS/MS (U3000
from Dionex and LTQ from Thermofisher) or 4800
MALDI-TOF/TOF instrument (Applied biosystem).
Peptide crosslinked analysis
A list of likely peptides, containing one undigested lysine
for trypsin or with more than one lysine for chymotryp-
sin, was used as lysine modification in order to compare
with unmodified peptide profile of the control without
BS3 and search LC-MS/MS data by Bioworks software
or for manual interpretation of MALDI-MS/MS data.
For intra-peptide cross-linking and BS3 single residue
modification, 138.068 and 156.0786 were added on
lysine as modifications respectively. The MS/MS spectra
of cross-linked peptides were manually confirmed.
Concerted two-end integration assay
The concerted two-end integration assay is a modification
of that previously described [24-26]. One pmole of the 5’-
labeled substrate used for strand transfer was incubated in
SST buffer (20 mM MES pH 6,4, 20 mM KCl, 5% glycerol,
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on ice with 7 pmol of IN wt or 56 pmoles of IN 1–105
(or mutant K105C) and 7 pmoles of IN 106–404 for
complementation assay. Then 100 pmol of pUC18 DNA
were added and incubated at 37°C for 1 h in a final volume
of 15 μL. The reaction was stopped with 3 μL of 0.1 M
EDTA, 5% SDS plus 1 μL of proteinase K (20 mg/mL) and
incubated at 55°C for 1 h. The reaction products were
separated by electrophoresis on 1% agarose gels. The gel
was dried and exposed on a Phosphor-Imager (Bio-Rad).
Cysteine crosslinking
Just prior to use, the IN 1–105 and K104C IN 1–105 were
adjusted to 0.8 mg/mL and ZnSO4 (10 μM final) was
added to chelate the cysteines of the zinc binding motif.
The proteins were kept on ice for 30 min. The bifunc-
tional maleimide-coupled crosslinking agent BMOE
(span arm 8 Å) and BM(PEG)2 (span arm 14.7 Å) were
prepared in DMSO just prior to use. The crosslinker was
added to the protein solution at a different crosslinker/
protein ratio. The reaction mixture was left on ice for
60 min and the crosslinker excess was quenched with
10 mM DTT for 30 min with further 30 min on ice. The
reaction products were analyzed by SDS-PAGE and
protein were stained with Coomasie Brilliant Blue.
Monomer of N-terminal integrase
Integrase N-terminal 3D coordinates, residues 11 to 105,
was a modification of 3NNQ pdb file, where the three
selenomethionine residues in Chain A were edited to
methionine residues.
Dimeric complex
Integrase N-terminal dimer was built using 3D-Dock
suite and experimental crosslinking restraints. In sum-
mary, one monomer of N-terminal integrase was defined
to the program as a fixed structure and the other mono-
mer as mobile. FTDock program, based on the correl-
ation algorithm of Katchalski-Katzir plus an electrostatic
function, generated 10,000 possible complexes through
rotation and translation of the mobile monomer previ-
ous to the correlation calculations. Experimental cross
linking information was used as a filter (filter routine in
the suite) to select the complex that agreed with the dis-
tance restraint data [27]. After the model was selected,
Multidock routine was used to refine the side chains of
the amino acids involved in the interface and to perform
a rigid body energy minimization of the complex.
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